Vera Therapeutics Inc (VERA)
39.65
+0.96
(+2.48%)
USD |
NASDAQ |
Apr 26, 16:00
39.65
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics Cash from Investing (TTM): -39.43M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -39.43M |
| September 30, 2023 | -44.55M |
| June 30, 2023 | -63.22M |
| March 31, 2023 | -18.86M |
| December 31, 2022 | -70.55M |
| September 30, 2022 | -88.99M |
| June 30, 2022 | -86.55M |
| Date | Value |
|---|---|
| March 31, 2022 | -43.66M |
| December 31, 2021 | -4.204M |
| September 30, 2021 | 0.853M |
| June 30, 2021 | 0.853M |
| March 31, 2021 | 0.01M |
| December 31, 2020 | -0.042M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-88.99M
Minimum
Sep 2022
0.853M
Maximum
Jun 2021
-35.26M
Average
-39.43M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
| Vertex Pharmaceuticals Inc | -3.142B |
| Alpine Immune Sciences Inc | -55.56M |
| Fate Therapeutics Inc | 112.66M |
| Checkpoint Therapeutics Inc | -- |
| Mersana Therapeutics Inc | 119.88M |